Raia Drogasil S.A.
RADLY
$4.66
$0.071.48%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.66% | -1.69% | -0.31% | 6.03% | 12.31% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.66% | -1.69% | -0.31% | 6.03% | 12.31% |
| Cost of Revenue | 2.38% | -1.06% | 0.28% | 6.55% | 12.68% |
| Gross Profit | -0.03% | -3.18% | -1.68% | 4.84% | 11.44% |
| SG&A Expenses | 0.69% | -2.98% | -1.24% | 3.92% | 11.57% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 98.58% | 99.16% | 104.42% | 130.26% | -68.84% |
| Total Operating Expenses | 2.15% | -1.22% | 0.28% | 6.42% | 12.33% |
| Operating Income | -5.67% | -8.80% | -8.93% | 0.30% | 12.06% |
| Income Before Tax | -8.35% | -10.03% | -7.98% | 7.69% | 14.39% |
| Income Tax Expenses | -77.87% | -65.18% | -31.39% | 55.51% | 136.06% |
| Earnings from Continuing Operations | 9.42% | 1.51% | -3.42% | 1.95% | 1.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 44.71% | 57.81% | 79.96% | 65.82% | -65.26% |
| Net Income | 10.86% | 3.20% | -1.09% | 4.03% | 0.04% |
| EBIT | -5.67% | -8.80% | -8.93% | 0.30% | 12.06% |
| EBITDA | -4.38% | -7.36% | -7.90% | 0.32% | 10.30% |
| EPS Basic | 28.16% | 20.66% | -11.85% | -6.03% | -11.02% |
| Normalized Basic EPS | -1.90% | 0.72% | -20.36% | -7.48% | 3.70% |
| EPS Diluted | 28.11% | 20.53% | -11.87% | -6.06% | -11.07% |
| Normalized Diluted EPS | -2.13% | 0.60% | -20.29% | -7.51% | 3.71% |
| Average Basic Shares Outstanding | -16.39% | -16.78% | 16.12% | 15.04% | 16.06% |
| Average Diluted Shares Outstanding | -16.31% | -16.63% | 16.06% | 14.86% | 15.83% |
| Dividend Per Share | -38.54% | 13.10% | -36.43% | -63.74% | 213.81% |
| Payout Ratio | -0.09% | -0.02% | -0.08% | -0.12% | 0.05% |